Congestive Heart Failure Market Size in the 7MM was ~USD 6 Billion in 2022 | DelveInsight

DelveInsight’s “Congestive Heart Failure Market Insights, Epidemiology, and Market Forecast – 2032” report delivers an in-depth understanding of Congestive Heart Failure, historical and forecasted epidemiology as well as the Congestive Heart Failure market trends in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom, and Japan.

 

Key Takeaways from the Congestive Heart Failure Market Research Report

  • The increase in Congestive Heart Failure Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
  • As per DelveInsight analysis, the Congestive Heart Failure Market is anticipated to witness growth at a considerable CAGR.
  • The leading Congestive Heart Failure Companies working in the market include Novartis, Boehringer Ingelheim, Eli Lilly, Bayer, Merck, AstraZeneca, Amgen, Otsuka Pharmaceutical, Cytokinetics, Mesoblast, Novo Nordisk, Lexicon Pharmaceuticals, scPharmaceuticals, Bristol-Myers Squibb, Intra-Cellular Therapies, Tenax Therapeutics, BioCardia, and others.
  • Promising Congestive Heart Failure Pipeline Therapies in the various stages of development include Lixivaptan, KW-3902IV, Irbesartan, rolofyline, and others.
  • April 2024:- Boehringer Ingelheim- Post Marketing Surveillance on Long Term Drug Use of JARDIANCE® Tablets in Patients With Chronic Heart Failure in Japan. Study objective is to investigate the safety and effectiveness of long-term daily use of JARDIANCE® Tablets in patients with chronic heart failure (CHF) under real-world use.
  • March 2024:- Nihon Kohden- Track changes in non-invasive central venous pressure across hospital stay and relationship with readmission. Determining the degree of congestion is important in deciding appropriate timing for discharging hospitalized heart failure patients. Central venous pressure (CVP) reflects the returning blood volume to the heart and can guide therapy to relieve congestion. However, the conventional method used to measure CVP has notable limitations as it is an invasive procedure that requires placement of a central venous catheter.

 

Discover which therapies are expected to grab the Congestive Heart Failure Market Share @ Congestive Heart Failure Market Outlook

 

Congestive Heart Failure Overview

 Congestive Heart Failure (CHF) is a chronic medical condition where the heart is unable to pump blood efficiently enough to meet the body’s needs. It typically occurs when the heart muscle becomes weakened or damaged, leading to a decrease in its ability to contract effectively or to relax properly between beats. As a result, blood flow out of the heart is reduced, causing blood to back up into the veins leading to the heart and causing congestion in various parts of the body.

 

Congestive Heart Failure Epidemiology Insights

The epidemiology section of Congestive Heart Failure offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

 

Download the report to understand which factors are driving Congestive Heart Failure Epidemiology trends @ Congestive Heart Failure Epidemiological Insights

 

Congestive Heart Failure Drugs Market

The Congestive Heart Failure Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Congestive Heart Failure signaling in Congestive Heart Failure are likely to uncover new therapeutic targets and further expand treatment options for patients.

 

Congestive Heart Failure Treatment Market Landscape

The Congestive Heart Failure treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Congestive Heart Failure has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

 

To know more about Congestive Heart Failure treatment guidelines, visit @ Congestive Heart Failure Treatment Market Landscape

 

Congestive Heart Failure Market Outlook

The report’s outlook on the Congestive Heart Failure market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Congestive Heart Failure therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Congestive Heart Failure drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Congestive Heart Failure market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.

 

Congestive Heart Failure Drugs Uptake

The drug chapter of the Congestive Heart Failure report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Congestive Heart Failure.

 

Major Congestive Heart Failure Companies

Several Congestive Heart Failure Companies working in the market include Novartis, Boehringer Ingelheim, Eli Lilly, Bayer, Merck, AstraZeneca, Amgen, Otsuka Pharmaceutical, Cytokinetics, Mesoblast, Novo Nordisk, Lexicon Pharmaceuticals, scPharmaceuticals, Bristol-Myers Squibb, Intra-Cellular Therapies, Tenax Therapeutics, BioCardia, and others

 

Learn more about the FDA-approved drugs for Congestive Heart Failure @ Drugs for Congestive Heart Failure Treatment

 

Scope of the Congestive Heart Failure Market Research Report

  • Coverage- 7MM
  • Congestive Heart Failure Companies- Novartis, Boehringer Ingelheim, Eli Lilly, Bayer, Merck, AstraZeneca, Amgen, Otsuka Pharmaceutical, Cytokinetics, Mesoblast, Novo Nordisk, Lexicon Pharmaceuticals, scPharmaceuticals, Bristol-Myers Squibb, Intra-Cellular Therapies, Tenax Therapeutics, BioCardia, and others
  • Congestive Heart Failure Pipeline Therapies- Lixivaptan, KW-3902IV, Irbesartan, rolofyline, and others.
  • Congestive Heart Failure Market Dynamics: Congestive Heart Failure Market Drivers and Barriers
  • Congestive Heart Failure Market Access and Reimbursement, Unmet Needs and Future Perspectives

 

Discover more about Congestive Heart Failure Drugs in development @ Congestive Heart Failure Clinical Trials Assessment

 

Table of Content

1. Key Insights

2. Report Introduction

3. Executive Summary

4. Key Events

5. SWOT Analysis

6. Congestive Heart Failure (CHF) Market Overview at a Glance

7. Disease Background and Overview

8. Treatment

9. Heart Failure with Preserved Ejection Fraction: Diagnosis and Management (2017)

10. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure (2021)

11. JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure (Update From 2017)

12. American College of Cardiology (ACC), American Heart Association (AHA), and HF Society of America (HFSA) (2021)

13. Chronic Heart Failure in Adults: Diagnosis and Management (NICE Guidelines 2018)

14. Acute Heart Failure: Diagnosis and Management (NICE Guidelines 2014)

15. Epidemiology and Patient Population

16. Country Wise-Epidemiology of HF

18. Patient Journey

19. Marketed Drugs

20. Emerging Drugs

21. Congestive Heart Failure (CHF): Seven Major Market Analysis

22. Unmet Needs

23. Market Access and Reimbursement

24. Appendix

25. DelveInsight Capabilities

26. Disclaimer

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Congestive Heart Failure Market Size in the 7MM was ~USD 6 Billion in 2022 | DelveInsight

Chronic Spontaneous Urticaria Market Size in the 7MM was ~USD 2100 Million in 2022 | DelveInsight

DelveInsight’s “Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast – 2032” report delivers an in-depth understanding of chronic spontaneous Urticaria, historical and forecasted epidemiology, as well as the chronic spontaneous Urticaria market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

 

Key Takeaways from the Chronic Spontaneous Urticaria Market Research Report

  • The increase in Chronic Spontaneous Urticaria Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
  • As per DelveInsight analysis, the Chronic Spontaneous Urticaria Market is anticipated to witness growth at a considerable CAGR.
  • As per DelveInsight analysis, there were approximately 4,154,234 total Chronic Spontaneous Urticaria diagnosed prevalent cases in the 7MM, in 2022. These cases are projected to increase during the forecast period (2023-2034).
  • As per DelveInsight analysis among EU4 and the UK, there was a higher female affected population for e.g. Germany accounted for around 97,142 male and 229,935 females affected from CSU in 2022. These cases are expected to change during the forecast period (2023-2034).
  • The leading Chronic Spontaneous Urticaria Companies working in the market include Novartis, Sanofi Pharmaceutical, Genentech, AstraZeneca, Kiniksa Pharmaceuticals, Ltd, United BioPharma, GlaxoSmithKline, Allakos, Eli Lilly and Company and others.
  • Promising Chronic Spontaneous Urticaria Pipeline Therapies in the various stages of development include Dupilumab SAR231893, CT-P39, EU-approved Xolair, Ligelizumab, Oral EP262, and others.
  • April 2024:- Escient Pharmaceuticals, Inc announced a study of Phase 2 clinical trials for Oral EP262. Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects with Chronic Spontaneous Urticaria.
  • April 2024:- Sanofi- Master Protocol of Three Randomized, Double-blind, Placebo Controlled, Multi-center, Parallel-group Studies of Dupilumab in Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite the Use of H1 Antihistamine Treatment in Patients naïve to Omalizumab and in Patients Who Are Intolerant or Incomplete Responders to Omalizumab.

 

Discover which therapies are expected to grab the Chronic Spontaneous Urticaria Market Share @ Chronic Spontaneous Urticaria Market Outlook

 

Chronic Spontaneous Urticaria Overview

Urticaria is a common and heterogeneous inflammatory skin disorder with or without associated angioedema. It presents with wheals, angioedema, or both due to activation and degranulation of skin mast cells, followed by the release of histamine and other mediators leading to sensory nerve activation, vasodilatation, plasma extravasation, and cellular recruitment. It is classified as acute or chronic, depending on whether the onset of episodes lasts for less or >6 weeks, respectively.

 

Chronic Spontaneous Urticaria Epidemiology Insights

The epidemiology section of Chronic Spontaneous Urticaria offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

  • Total Chronic Spontaneous Urticaria Diagnosed Prevalent Cases
  • Chronic Spontaneous Urticaria Type-specific Cases
  • Chronic Spontaneous Urticaria Gender-specific Cases
  • Chronic Spontaneous Urticaria Age-specific Cases
  • Chronic Spontaneous Urticaria Severity-specific Cases

 

Download the report to understand which factors are driving Chronic Spontaneous Urticaria Epidemiology trends @ Chronic Spontaneous Urticaria Epidemiological Insights

 

Chronic Spontaneous Urticaria Drugs Market

The Chronic Spontaneous Urticaria Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Chronic Spontaneous Urticaria signaling in Chronic Spontaneous Urticaria are likely to uncover new therapeutic targets and further expand treatment options for patients.

 

Chronic Spontaneous Urticaria Treatment Market Landscape

Chronic Spontaneous Urticaria treatment is generally initiated with no sedating antihistamines in the daytime and sedating antihistamines at night. H2-antihistamines are often combined with H1 to achieve better symptom control in CSU and are added if individuals complain of indigestion or acidity. The most commonly used H2 antihistamine for CSU is ranitidine.

 

To know more about Chronic Spontaneous Urticaria treatment guidelines, visit @ Chronic Spontaneous Urticaria Treatment Market Landscape

 

Chronic Spontaneous Urticaria Market Outlook

The report’s outlook on the Chronic Spontaneous Urticaria market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Chronic Spontaneous Urticaria therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Chronic Spontaneous Urticaria drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Chronic Spontaneous Urticaria market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.

 

Chronic Spontaneous Urticaria Drugs Uptake

 

Remibrutinib (LOU064): Novartis Pharmaceuticals

Remibrutinib is an oral treatment that potently and selectively inhibits bruton’s tyrosine kinase (BTK) enzyme, which plays a critical role in the inflammatory activity of certain immune cells, such as B cells and microglia. Remibrutinib inhibits degranulation induced by IgE cross-linking in mast cells and basophils and the activation triggered by factors present in the sera of spontaneous and inducible chronic urticaria patients. Recently, in its Phase III REMIX-1 and REMIX-2 trials, the drugs showed clinically meaningful and statistically significant reduction in weekly urticaria activity (UAS7), itch (ISS7) and hives (HSS7) at Week 12 compared to placebo. Remibrutinib was well-tolerated and demonstrated a favorable safety profile with rates of overall adverseevents comparable to placebo and balanced liver function tests across both studies. Studies are ongoing with final readout and regulatory submissions anticipated in 2024.

 

DUPIXENT (dupilumab): Sanofi/Regeneron

DUPIXENT is a human monoclonal IgG4 antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling by specifically binding to the IL-4Rα subunit shared by the IL-4 and IL-13 receptor complexes. Dupilumab inhibits IL-4 signaling via the ‘Type I’ receptor and both IL-4 and IL-13 signaling through the ‘Type II’ receptor. Multiple cell types that express IL-4Rα. DUPIXENT is approved for multiple indications, including atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), eosinophilic esophagitis, and prurigo nodularis. In July 2021, the Phase III trial met its primary and key secondary endpoints at 24 weeks, showing DUPIXENT nearly doubled reduction in itch and urticaria activity scores. Sanofi and Regeneron files and sNDA for DUPIXENT in chronic spontaneous urticaria, for which the US FDA issues a CRL stating that additional efficacy data is required to support an approval. The drug is currently investigated in Phase III trials in patients naïve to omalizumab or intolerant or incomplete responders to omalizumab, with results expected in late 2024 for DUPIXENT in CSU in biologic-naïve patients.

 

TEZSPIRE (tezepelumab): AstraZeneca/Amgen

TEZSPIRE (tezepelumab [AMG 157]) is being developed by AstraZeneca in collaboration with Amgen as a first-in-class human monoclonal antibody that inhibits the action of blocks thymic stromal lymphopoietin (TSLP), a key epithelial cytokine that sits at the top of multiple inflammatory cascades and is critical in the initiation and persistence of allergic, eosinophilic and airway inflammation diseases. TSLP, IL-25, and IL-33 are released following different triggers on epithelia and start the Th2 inflammatory response, mediating T-cell polarization in Th2 cells. Tezepelumab, with its inhibitory action of TSLP, appears to prevent and treat the lesional skin of patients with CSU. TEZSPIRE is currently approved for treating severe asthma in the US, EU, Japan, and other countries. Moreover, TEZSPIRE is approved in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 and older with severe asthma. TEZSPIRE is in development for CSU (Phase II completed) and other potential indications, including COPD, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis.

 

Major Chronic Spontaneous Urticaria Companies

Several Chronic Spontaneous Urticaria Companies working in the market include Novartis, Sanofi Pharmaceutical, Genentech, AstraZeneca, Kiniksa Pharmaceuticals, Ltd, United BioPharma, GlaxoSmithKline, Allakos, Eli Lilly and Company and others.

 

Learn more about the FDA-approved drugs for Chronic Spontaneous Urticaria @ Drugs for Chronic Spontaneous Urticaria Treatment

 

Scope of the Chronic Spontaneous Urticaria Market Research Report

  • Coverage- 7MM
  • Chronic Spontaneous Urticaria Companies- Novartis, Sanofi Pharmaceutical, Genentech, AstraZeneca, Kiniksa Pharmaceuticals, Ltd, United BioPharma, GlaxoSmithKline, Allakos, Eli Lilly and Company and others.
  • Chronic Spontaneous Urticaria Therapies- Dupilumab SAR231893, CT-P39, EU-approved Xolair, Ligelizumab, Oral EP262, and others.
  • Chronic Spontaneous Urticaria Market Dynamics: Chronic Spontaneous Urticaria Market Drivers and Barriers
  • Chronic Spontaneous Urticaria Market Access and Reimbursement, Unmet Needs and Future Perspectives

 

Discover more about Chronic Spontaneous Urticaria Drugs in development @ Chronic Spontaneous Urticaria Clinical Trials Assessment

 

Table of Content

1. Key Insights

2. Report Introduction

3. Chronic Spontaneous Urticaria Market Overview at a Glance

4. Methodology of Chronic Spontaneous Urticaria Epidemiology and Market

5. Executive Summary of Chronic Spontaneous Urticaria

6. Key Events

7. Disease Background and Overview

8. Patient Journey

9. Epidemiology and Patient Population

10. Marketed Drugs

11. Emerging Drugs

12. Chronic Spontaneous Urticaria: Market Analysis

13. Key Opinion Leaders’ Views

14. SWOT

15. Unmet needs

16. Market Access and Reimbursement

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Spontaneous Urticaria Market Size in the 7MM was ~USD 2100 Million in 2022 | DelveInsight

Logistics Automation Market Trends, Size, Share, Growth, Industry Analysis, Advance Technology and Forecast 2028

“Dematic (US), Honeywell Intelligrated (US), Daifuku (Japan), Oracle (US), SAP (Germany),IBM(US) ,SSI Schaefer (Germany), Knapp (Austria), Manhattan Associates (US), Swisslog (Switzerland), Blue Yonder (US),Mantis(US),Murata Machinery (Japan), TGW Logistics Group (Austria), Jungheinrich (Germany), System Logistics (Italy), ABB (Switzerland), and Logiwa(US).”
Logistics Automation Market by Component, Function, Logistics Type (Procurement/Inbound Logistics, Sales/Outbound Logistics) Software Application (Inventory Management, Order Management), Vertical and Region – Global Forecast to 2028

The global logistics automation market size is projected to grow from USD 32.7 billion in 2023 to USD 51.2 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period. The logistics industry is benefiting from advances in technology, such as robotics, artificial intelligence, and the Internet of Things (IoT) in logistics automation market.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=83657139

By Components, Hardware segment to account for largest market share during the forecast period

Hardware account for largest market share during the forecast period and these systems include hardware segment includes Autonomous Mobile Robots (AMRs), Automated Guided Vehicles (AGVs), Automated Storage and Retrieval Systems (AS/RS), Automated Sorting and Conveyor Systems, De-palletizing/Palletizing Systems, and Automatic Identification and Data Collection (AIDC). AMRs are becoming increasingly popular in warehouses and distribution centers, as they can autonomously move goods around the facility without the need for human intervention. This technology can help to reduce labor costs and increase efficiency.

By Software Application, Shipping management segment to account for largest market share during the forecast period

Shipping management account for largest market share during the forecast period .Shipping management is the process of effectively managing the goods transportation into and out of storage to the warehouse in real time. The warehouse management solution offers an on-demand, web-based solution that helps companies increase order throughput, accuracy, and speed by streamlining the picking and shipping process when the order is received. Inventory levels are automatically updated into the warehouse system after each shipment is sent to ensure accurate, real-time inventory visibility and control.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=83657139

Unique Features in the Logistics Automation Market

RPA is used by logistics automation solutions to automate repetitive operations including order processing, inventory tracking, and data entry, increasing operational efficiency and lowering human error.

Advanced Material Handling (AMR) systems are utilised in material handling, products movement, and warehousing operations. They provide versatility, adaptability, and scalability for managing intricate situations and completing diverse logistics duties.

Proactive decision-making and resource allocation are made possible by logistics automation, which combines forecasting algorithms and predictive analytics to optimise demand planning, inventory management, and route optimisation.

By offering unchangeable records of transactions, facilitating real-time tracking and tracing of commodities, and guaranteeing data integrity and authenticity throughout the supply chain, blockchain technology improves supply chain visibility and transparency.

Logistics automation systems optimise storage space, reduce stockouts, and increase order fulfilment rates by automating inventory replenishment, utilising IoT sensors, RFID tags, and AI-driven analytics.

Major Highlights of the Logistics Automation Market

In order to improve product offerings, increase market reach, and meet changing customer expectations in the dynamic logistics landscape, logistics automation suppliers are collaborating and developing strategic alliances with technology providers, logistics service providers, and industry stakeholders.

The demand for automation solutions that lower energy consumption, emissions, and waste in transportation and warehousing operations while complying with legal and environmental regulations is being driven by the increased focus on sustainability in logistics operations.

Transportation management systems (TMS) and digital freight platforms are revolutionising the way freight management is done. They make it possible for real-time visibility, optimisation, and cooperation throughout the supply chain, which lowers costs and increases efficiency.

In order to provide faster, safer, and more effective products movement, the logistics automation industry is witnessing the rise of autonomous cars, drones, and unmanned aerial vehicles (UAVs) for last-mile deliveries, warehouse operations, and transportation logistics.

In order to satisfy customer demand and optimise inventory levels, retailers are requiring adaptable and scalable logistics automation solutions that can seamlessly interact with numerous sales channels and fulfilment models. This demand is being driven by the growth of omnichannel commerce.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=83657139

Top Companies in the Logistics Automation Market

The major vendors covered in the logistics automation market include Dematic (US), Honeywell Intelligrated (US), Daifuku (Japan), Oracle (US), SAP (Germany),IBM(US) ,SSI Schaefer (Germany), Knapp (Austria), Manhattan Associates (US), Swisslog (Switzerland), Blue Yonder (US),Mantis(US),Murata Machinery (Japan), TGW Logistics Group (Austria), Jungheinrich (Germany), System Logistics (Italy), Zebra Technologies (US), ABB (Switzerland), BEUMER Group (Germany),Korber(Germany), O9 Solutions(US), JR Automation(US), Automated Logistics Systems(US),SBS Toshiba Logistics (Japan), SAVOYE(France), Symbotic(US), Locus Robotics(US), GreyOrange (US), Eyesee (Hardis Group) (France), Falcon Autotech (India), Logistically(US),and Logiwa(US).These players have adopted various growth strategies, such as partnerships, business expansions, mergers and acquisitions, partnerships, agreements, and collaborations, new product launches to expand their presence in the logistics automation market. Partnerships and new product launches have been the most adopted strategies by major players from 2020 to 2022, which helped them innovate their offerings and broaden their customer base.

Daifuku was founded in 1937 and is headquartered in Osaka, Japan. It offers consulting, designing, manufacturing, planning and engineering, installation and operation, and after-sales services for logistics systems and automated material handling equipment. The core businesses of the company are intralogistics, cleanroom, automotive, airport technologies, auto wash, and electronics. Daifuku has operations worldwide, with affiliate companies and offices in 26 countries. Key products offered by the company include manufacturing and distribution systems, semiconductor manufacturing system, flat panel display manufacturing system, automobile assembly line systems, airport products, and car washing machines. The company also provides material handling products, including conveyor systems, AGVs, ASRS, sorting systems, and picking systems.

SAP was founded in 1972 and is headquartered in Walldorf, Germany. The company is a leading provider of enterprise application software. It specializes in analytics and business intelligence services. SAP has expertise in various technologies, including analytics, application platform and infrastructure, data management, IT management, and security software. SAP operates through two segments: Cloud and Software, and Services. SAP offers warehouse and transportation management system solutions through the Cloud and Software segment. It also caters to various verticals that include energy and natural resources, financial services, consumer industries, discrete industries, service industries, and public services.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/logistics-automation-market-83657139.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Logistics Automation Market Trends, Size, Share, Growth, Industry Analysis, Advance Technology and Forecast 2028

Cheese Powder Market Size, Share, Trends, Business Opportunities, Industry Overview, and Leading Players

“MarketsandMarkets™”
Cheese Powder Market by Type (Cheddar, Mozzarella, American Cheese, Blue Cheese, Parmesan), Application (Bakery & Confectionery, Sweet & Savory Snacks, Sauces, Dressings, Dips, and Condiments, Ready Meals), Origin and Region – Global Forecast to 2028

The global cheese powder market is estimated at USD 630 million in 2023 and is projected to reach USD 895 million by 2028, at a CAGR of 7.3% from 2023 to 2028. The consumption pattern of cheese is observed to shift from the traditional way to a more advanced and innovative way, such as the consumption of low fat and low sodium cheese powders, which would impart more flavor to their food products. Thus, cheese powders are expected to be accepted and grow at a good pace in the coming years.

Cheese Powder Market

What is cheese powder?

Cheese powder is a dehydrated form of cheese that has been processed into a fine powder. It’s typically made by drying cheese and then grinding it into a powder form. This powder can vary in flavor and texture depending on the type of cheese used and the processing methods employed. It’s commonly used as a flavoring agent in various food products like snacks, sauces, dips, and seasonings. Cheese powder is convenient for adding a cheesy flavor to dishes without the need for refrigeration or worrying about spoilage.

Cheese Powder Market Trends

The cheese powder market has witnessed several trends in recent years. Here are some key observations:

1. Increasing Demand in Food Industry: Cheese powder has gained popularity across the food industry due to its convenience, long shelf life, and ability to add cheese flavor to a variety of products. This demand is particularly pronounced in the snack food, bakery, and convenience food sectors.

2. Growing Preference for Natural Ingredients: With consumers becoming more health-conscious and demanding transparency in food ingredients, there’s a notable shift towards natural cheese powders made from real cheese rather than artificial flavors. Manufacturers are responding by offering products with cleaner labels, free from additives and artificial preservatives.

3. Expansion of Product Applications: Cheese powder is no longer limited to traditional uses in macaroni and cheese or snack seasonings. Its versatility has led to its incorporation in a wide range of products such as sauces, dips, dressings, soups, and even beverages, contributing to the expansion of the market.

4. Innovations in Flavor Profiles: To cater to diverse consumer preferences, cheese powder manufacturers are innovating with new flavor profiles beyond the conventional cheddar and mozzarella. This includes exotic cheese varieties like blue cheese, gouda, and parmesan, as well as flavored blends incorporating herbs, spices, or even heat from chili peppers.

5. Rising Demand for Plant-Based Alternatives: With the growing popularity of plant-based diets, there’s a rising demand for vegan cheese powders made from plant sources such as nuts, seeds, or nutritional yeast. These alternatives are not only appealing to vegans and vegetarians but also to consumers seeking healthier and environmentally sustainable options.

Cheese Powder Market Opportunities: Rapidly growing market of processed and packaged food in developing countries

With favorably changing economic conditions and developments, there is an increase in the disposable income of consumers. This rise in disposable income has resulted in higher purchasing power of consumers, which in turn has increased the household expenditure, wherein the consumers are increasingly spending on processed & packaged foods. Cheese powder is extensively used in packaged and processed food as a flavorant. The increasing disposable income in emerging economies can be analyzed by the growth in GDP (PPP) of leading countries in 2015.

The rise in urbanization in developing countries is expected to create opportunities for the global cheese powder market. Urbanization often leads to changes in lifestyle and dietary habits. With fast-paced urban lives, people are seeking convenient and time-saving food options that do not compromise on taste and nutritional value. Cheese powder, known for its long shelf life and versatility, aligns perfectly with this need. It can be easily incorporated into a variety of dishes, ranging from instant pasta meals to ready-to-eat snacks, catering to the on-the-go urban lifestyle. According to the FAO, rapid economic development, income growth, and urbanization are leading to changes in dietary patterns of people in Asia. A shift is observed from staple food towards including processed & packaged food products in their food intake. Moreover, growth in retail channels such as supermarkets and hypermarkets in urban areas is expected to increase the availability of processed & packaged food. With the rising demand for packaged foods such as snacks, bakery & confectionery products, and ready to eat meals, the demand for cheese powder is likely to grow in the future.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103908380

Based on application, Sauces, dressings, dips, and condiments products is estimated to account for the largest market share of the cheese powder market.

Sauces, dressings, dips, and condiments are commonly used to enhance the flavor of various dishes. When combined with cheese powder, they can create a rich and savory taste profile that appeals to consumers. The combination of different flavors can lead to unique culinary experiences, driving demand for cheese powder in both the consumer and food service sectors. The food service sector, including restaurants and cafes, often uses cheese powder as a cost-effective and flavor-boosting ingredient. By incorporating cheese powder into sauces, dressings, and dips, foodservice establishments can offer unique menu items that stand out to customers.

The North America market is projected to contribute the largest share for the cheese powder market.

North America, especially the United States, has been a significant consumer of processed and convenience foods, which often include cheese-flavored snacks and products. This has contributed to the demand for cheese powder as an ingredient. Consumers have shown a growing preference for convenient, ready-to-eat, and portable snack options. Cheese powder is often used to add flavor to such products, aligning with this trend. Cheese powder is a versatile ingredient that provides a concentrated cheese flavor. Its use in various food items helps enhance taste profiles and can make products more appealing to consumers.

Top Companies in the Cheese Powder Market

Land O’Lakes, Inc. (US), Kerry Group Plc (Ireland), Fonterra Co-operative Group Limited (New Zealand), Archer Daniels Midland (US), and Lactosan A/S (Denmark) are among the key players in the global cheese powder market. These players in this market are focusing on increasing their presence through partnership and collaborations. These companies have a strong presence in North America, Asia Pacific and Europe.

LAND O’LAKES, INC. (US)

Land O’Lakes, Inc. is a well-established farmer- and retailer-owned cooperative that was originally founded with the aim of collaborating to create new market opportunities. The company produces dairy products, animal feed and crop seed in the US. In 1921, it was formed as a cooperative designed to meet the needs of dairy farmers located in the midwestern US. It operates our business through three primary segments: dairy foods, animal feed and crop seed. The company also includes other segments and a diverse group of joint ventures and investments.

The dairy foods business segment of Land O’Lakes is responsible for offering products related to the cheese powder market. Within this segment, Land O’Lakes produces, markets, and sells an array of dairy products, including butter, spreads, cheese, and other related items. These products are marketed under the brand name “Land O Lakes” Ingredients. The company currently operates in US only.

KERRY GROUP PLC (Ireland)

Kerry Group Plc is a leading manufacturer of food ingredients and flavors. It is engaged in the manufacturing and marketing of food ingredients and flavors for the food, beverage, and pharmaceutical industries. The company operates through two business segments: ingredients & flavors and consumer foods. Kerry offers a wide array of food ingredients for food processing centers and markets globally. Its product portfolio also consists of coating systems, sweet ingredients, fruit preparations, cheese & dairy ingredients, and functional dairy & confectionary ingredients needed by the food processing and service industries. The group offers its products under the brand names of Mattessons, Richmond, Wall’s, Ballyfree, Denny, Homepride, Dawn, and Kelly Spring.

The group supplies more than 18,000 consumer foods, food ingredients, and flavor products to customers in 140 countries across Europe, Middle East, and Africa (EMEA); the Americas; and Asia-Pacific. The group has 147 manufacturing facilities in 25 countries.

FONTERRA CO-OPERATIVE GROUP LIMITED (New Zealand)

Fonterra Co-operative Group Limited, commonly known as Fonterra, is a leading global dairy co-operative based in New Zealand. The company’s dairy ingredients and solutions brand, NZMP (New Zealand Milk Products), has gained international recognition and stands as a testament to Fonterra’s expertise in the dairy industry. Fonterra’s NZMP brand boasts a vast international footprint, with offices in 14 global locations and a strong reseller network. With customers in over 130 countries, NZMP holds the distinction of being the world’s leading dairy exporter.

Apart from New Zealand, Fonterra has a significant presence in various key regions like North America, Europe, and Asia Pacific. In Australia, NZMP processes around 20% of the country’s milk, making it a substantial contributor to the dairy industry in the region. In Europe, the company’s specialized team produces high-quality ingredients and mozzarella, leveraging the Netherlands’ strategic location. Moreover, through its joint venture, Columbia River Technologies (CRT), Fonterra produces Grade A Whey Ingredients sourced from the US, catering to the North American market.

ADM (US)

Archer Daniels Midland Company (ADM) produces food & beverage ingredients, feed & feed ingredients, industrial ingredients, biofuels, and naturally derived alternatives to industrial chemicals.  It operates through four segments- Agriculture services & oilseed: activities related to the agricultural raw material origination, marketing, transportation, and storage, as well as crushing and further processing of oilseeds; Carbohydrate solutions: engaged in corn and wheat wet and dry milling and other activities; Nutrition: offers Food, beverages, nutritional supplements, and feed and premix for livestock, aquaculture, and pet food are all served by the Nutrition segment. Plant-based proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, enzymes, botanical extracts, and other specialty food and feed ingredients are among the ingredients and solutions manufactured, sold, and distributed by this segment; and others segment: Other Business includes the Company’s remaining operations such as Investor Services, Insurance activities and more.

Schedule a call with our Analysts to discuss your business needs: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=103908380

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cheese-powder-market-103908380.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Cheese Powder Market Size, Share, Trends, Business Opportunities, Industry Overview, and Leading Players

Food Antioxidants Market Size, Share, Trends, Business Opportunities, Industry Overview, and Leading Players

“MarketsandMarkets™”
Food Antioxidants Market by Source (Fruits & Vegetables, Oils, Spices & Herbs, Botanical Extracts, Gallic Acid & Petroleum), Application (Fats & Oils, Prepared Meat & Poultry, Bakery & Confectionery), Type, Form and Region – Global Forecast to 2028

The global food antioxidants market was valued at US$ 1.5 billion in 2022 and is poised to grow from US$1.6 billion in 2023 to US$2.2 billion by 2028, growing at a CAGR of 6.2% in the forecast period (2023–2028). Antioxidants are substances that stop the oxidation process, which could harm organisms’ cells and lead to the creation of free radicals. They can be acquired naturally from a variety of fruits and vegetables, including raspberries, spinach, and eggplant, or they can be produced artificially and used as additions for a variety of uses. In addition to being widely used as a preservative in many processed food goods, it is also widely employed as an additive for fuel, plastic, and latex. Additionally, it plays a crucial role in many pharmaceutical and cosmetic items. Also contributing to the market’s growth throughout the projected period will be the world’s growing population, and the high demand for processed foods will provide an explosive rise.

Food Antioxidants Market

What are Food Antioxidants?

Food antioxidants are compounds found in various foods that help protect the body’s cells from damage caused by harmful molecules called free radicals. Free radicals are produced naturally in the body during metabolism, but they can also come from external sources like pollution, UV radiation, and unhealthy diets.

Antioxidants work by neutralizing free radicals, which can otherwise cause oxidative stress and contribute to various health problems, including inflammation, heart disease, and cancer. Common food antioxidants include vitamins such as vitamin C and vitamin E, minerals like selenium and zinc, and phytochemicals found in fruits, vegetables, nuts, seeds, and herbs.

Consuming a diet rich in antioxidants is associated with numerous health benefits, including improved immune function, reduced risk of chronic diseases, and slower aging processes. Eating a diverse range of colorful fruits and vegetables is an excellent way to ensure you’re getting a variety of antioxidants in your diet.

Food Antioxidants Market Trends

The food antioxidants market has been experiencing several notable trends in recent years. Here are some of the key observations:

1. Growing Demand for Natural Antioxidants: There is a rising preference among consumers for natural antioxidants derived from plant sources such as fruits, vegetables, herbs, and spices. This trend is driven by increasing health consciousness and concerns regarding synthetic additives in food products.

2. Clean Label Movement: Consumers are increasingly seeking transparency in food labeling and are favoring products with clean labels, which include natural antioxidants. As a result, food manufacturers are reformulating their products to replace synthetic antioxidants with natural alternatives to meet this demand.

3. Expansion of Functional Foods Market: The functional foods market, which includes products fortified with antioxidants for health benefits, is expanding rapidly. Consumers are seeking foods and beverages that offer not only nutrition but also additional health-promoting properties, leading to the incorporation of antioxidants into a wide range of products.

4. Focus on Shelf-life Extension: Antioxidants play a crucial role in extending the shelf life of food products by inhibiting oxidation and preventing spoilage. With increasing consumer demand for convenient and longer-lasting food options, there is a growing interest in antioxidant-rich ingredients and formulations to enhance product stability and freshness.

5. Emergence of Novel Antioxidants: Research and development efforts are underway to identify and commercialize novel antioxidants with enhanced efficacy and stability. This includes exploring antioxidant compounds from unconventional sources such as microorganisms, algae, and by-products of food processing, as well as the development of synergistic antioxidant blends for optimized functionality.

Food Antioxidants Market Opportunities: Popularity of long shelf life of products due to usage of antioxidants as preservatives boosts market

Awareness about food antioxidants is low, and emerging economies such as China and India are experiencing high industrialization. As these emerging economies grow and attain high disposable income, their demand for food antioxidants is also rising. The Asia Pacific region is exhibiting increased demand for prepared and functional foods & beverages, and hence, the region’s food antioxidants market is expected to grow. The demand for food antioxidants is expected to grow at a modest pace in early adopting countries such as Japan and Germany and at an exponential rate in new & emerging markets such as Thailand, Malaysia, and other Asian countries.

The growing global population is putting more pressure on producers for the manufacturing, extraction, and maintenance of scarce resources. High energy prices and rising raw material costs are impacting food prices, thus affecting low-income consumers. Pressure on food supplies is being exacerbated by water shortages, particularly across Africa and Northern Asia. Advances in science and technology are helping in extending the shelf life of foods to a greater extent. The need for marketing food preservatives to the smallest of food & beverage manufacturers is expected to augment the market size.

Based on application, the prepared meat and poultry segment is projected to witness the highest CAGR during the forecast period.

Prepared meat & poultry products manufacturers use antioxidants for several reasons, primarily to preserve the quality and extend the shelf life of their products. Antioxidants are added to meat products to prevent or delay the oxidation process, which can cause meat to spoil and lose its flavor, texture, and nutritional value. Oxidation occurs when oxygen reacts with the fats in meat, causing them to become rancid and produce off-flavors and odors. To maintain the quality and freshness of meat for longer periods, exporters can incorporate antioxidants, which can either prevent or slow down the oxidation process. This becomes crucial for meat products that need to be transported over long distances or stored for extended periods before being sold. Commonly used antioxidants in the meat industry include Vitamin E, ascorbic acid (Vitamin C), and various plant-based extracts such as rosemary extract, green tea extract, and grape seed extract. Thus, the increase of prepared meat & poultry consumption potentially increase the usage of food antioxidants in the meat & poultry products.

The Asia Pacific market is projected to contribute the largest share for the food antioxidants market.

In 2022, the Asia Pacific region dominated the global market for food antioxidants, largely as a result of the growing demand from food manufacturers in developed nations to move their production facilities to emerging markets, where labor costs are low and establishment and production costs are low. The market revenue growth in the area has been fueled by this trend as well as the increased need for natural and synthetic food antioxidants for producing various food products.

Top Companies in the Food Antioxidants Market

Major key players operating in the food antioxidants market Archer Daniels Midland (US), BASF SE (Germany), International Flavors & Fragrances Inc. (US), Eastman Chemical Company (US) and DSM (The Netherlands).

Archer Daniels Midland (US)

Archer Daniels Midland Company (ADM) produces food & beverage ingredients, feed & feed ingredients, industrial ingredients, biofuels, and naturally derived alternatives to industrial chemicals. It operates through four segments- Agriculture services & oilseed, Carbohydrate solutions, Nutrition and Others. The Nutrition segment offers Food, beverages, nutritional supplements, and feed and premix for livestock, aquaculture, Plant-based proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, enzymes, botanical extracts, and other specialty food and feed ingredients are among the ingredients and solutions manufactured, sold, and distributed. The food antioxidant market related products are catered by the Nutrition business segment.

BASF SE (Germany)

BASF SE manufactures chemical products, operating in a variety of markets, including chemicals, plastics, performance products, agricultural solutions, and oil and gas. BASF SE operates through seven business segments-Chemicals, Materials, Industrial Solutions, Surface Technology, Nutrition & Care, Agricultural Solutions and Others segment (includes oil & gas and other technical services). In the Nutrition & Care segment, involving the Care Chemicals and Nutrition & Health divisions, they serve the growing and increasingly sophisticated demands for fast-moving consumer goods. This includes food and feed manufacturers, as well as pharmaceutical, cosmetics, detergent, and cleaner manufacturers. They also provide technical applications, crop protection, and nutrition solutions. The food antioxidant market related products are catered in this segment. It primarily operates in Europe and has an active presence in North America, Asia Pacific, South America, Africa, and the Middle East.

International Flavors & Fragrances Inc. (US)

International Flavors & Fragrances Inc. (IFF) is a global company that creates, manufactures, and supplies flavors, fragrances, and specialty ingredients for the food, beverage, consumer goods, and fragrance industries. The company operates through four business segments: Nourish, Health & Bioscience, Scent, and Pharma Solutions. The food antioxidant products are offered under its Health & Bioscience segment. The company has over 110 manufacturing facilities, 100 R&D centers, and customers worldwide, covering Asia, Europe, Africa, and the Americas. In 2021, IFF completed its merger with DuPont’s Nutrition & Biosciences business, creating a global ingredients and solutions leader serving consumer-oriented food and beverage, home and personal care, and health and wellness end markets. This combination is expected to drive long-term, sustainable growth through an expanded portfolio, R&D capabilities, and market positions in high-value ingredients categories.

DSM (The Netherlands)

The DSM (Dutch State Mines) is a global science-based company headquartered in the Netherlands that operates in the fields of health, nutrition, and materials. DSM was founded in 1902 as a state-owned mining company but has since diversified into various industries. The company operates through five business segments: Animal Nutrition & Health, Health, Nutrition & Care, Food & Beverage, Others and Corporate Activities. The food antioxidant market related products are catered by the Food & Beverage segment. The company assists its clients in developing customized solutions such as nutraceutical solutions, market-ready solutions, personalized nutrition solutions, premix solutions, and shelf-life solutions. The company also provides services such as application and technical services, innovation and R&D services, insights and marketing services, regulatory and quality services, and scientific services for their client base. The company has a presence in Europe, Africa, the Americas, Asia, and Australia. Alongside its strong global presence, the company has innovation centers in the US, the Netherlands, and Singapore to connect with its loyal customer base.

Schedule a call with our Analysts to discuss your business needs: 
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=91651246

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/food-antioxidants-market-91651246.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Food Antioxidants Market Size, Share, Trends, Business Opportunities, Industry Overview, and Leading Players

Water Treatment Chemicals Market Analysis, Size, Opportunities, Share, Top Suppliers, Growth, Regional Trends, Key Segments, Graph and Forecast to 2028

“Browse 259 market data Tables and 53 Figures spread through 282 Pages and in-depth TOC on “Water Treatment Chemicals Market””
Water Treatment Chemicals Market by Type (Flocculant & Coagulant, Corossion Inhibitors, Scale Inhibitors, Biocides & Disinfectants, Chelating Agents), Source, End-use (Residential. Commercial & Industrial), and Region – Global Forecast to 2028

The global water treatment chemicals market size is estimated to be USD 43.9 billion by 2028 from USD 36.7 billion in 2023, at a CAGR of 3.6%. The market growth is driven by increasing demand for chemically treated water in various end-use industries, Stringent water and wastewater regulations, and Increasing water pollution is driving the demand for water treatment chemicals. However, alternative water treatment technologies, and high costs of water treatment, maintenance, and energy restrain the market.  

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=342  

Ecolab Inc. (US), Dow Inc.(U.S.), Kemira Oyj (Finland), Solenis LLC (US), and BASF SE (Germany) are some of the established players in the water treatment chemicals market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.

Ecolab Inc.

Ecolab Inc. is a global leader in water, hygiene, and energy technologies, offering sustainable solutions to businesses across various industries. The company operates through three major segments, namely, global industrial, global institutional, and global healthcare & life sciences. The company offers water treatment products and services to various industrial customers such as food & beverage processing, chemical, mining & primary metals, power generation, pulp & paper, and commercial laundry. Ecolab operates at nearly three million customer locations, serving more than 40 industries across over 170 countries.

Kemira Oyj

Kemira Oyj is one of the global chemical companies serving its customers in water intensive industries. It offers expertise, application know-how, and chemicals that improve product quality, process, and resource efficiency. It operates through two business segments: pulp & paper, and industry & water. The company is engaged in providing chemicals to water-intensive industries for various water treatment processes. WTCs produced by the company are used in municipal and oil & mining industries.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=342 

Kemira has a global presence with sales presence in more than 100 countries. The company also has 63 manufacturing facilities and 3 R&D centers across different region including Europe, North America, and Asia Pacific.

BASF SE

BASF SE is one of the leading global chemical companies. The company operates through six business segments: chemicals, materials, industrial solutions, surface technologies, nutrition & care, and agricultural solutions. It offers WTCs through its industrial solutions business segment under energy & resources sub-segment. The company offers various types of WTCs such as coagulants & flocculants, corrosion inhibitors, defoamers, biocides, and antiscalants & dispersants under different brand names including Magnafloc, Basocorr, Solutrix, and Alcomer. BASF SE operates in more than 90 countries through its subsidiaries. The company primarily operates in Europe, and it has strong presence in North America and Asia Pacific regions. The company also has a strong manufacturing presence with more than 232 production sites worldwide.

Solenis

Solenis LLC is a global specialty chemicals and solutions provider. The company serves its products to various end-use industries such as biorefining, chemical processing, industrial water, mining & mineral processing, municipal, oil & gas, packaging paper & board, and power generation. The company offers a wide range of process, functional, water treatment chemicals. Solenis has a global presence with its 71 manufacturing facilities across North America, Europe, Asia Pacific, South America, and Africa. The company has a sales presence in more than 130 countries across the globe.

Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=342  

Dow Inc.

Dow Inc. was incorporated on August 30, 2018, under Delaware law, to serve as a holding company for The Dow Chemical Company and its consolidated subsidiaries. The company operates through four business segments: packaging & specialty plastics, performance materials & coatings, industrial intermediates & infrastructure, and corporate. The company offers WTCs through the industrial solutions sub-segment, which is a part of the industrial intermediates & infrastructure segment. It offers its products to various end-use industries such as pulp & paper, oil & gas, and food & beverage. The company is spread across North America, Latin America, Europe, the Middle East & Africa, and Asia Pacific. It operates in 31 countries with 109 manufacturing facilities.

Read Our Trending Press Release Below:

Liquid Ring Compressor Market

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/water-treatment-342.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Water Treatment Chemicals Market Analysis, Size, Opportunities, Share, Top Suppliers, Growth, Regional Trends, Key Segments, Graph and Forecast to 2028

Blue Atlas Marketing Shares Affirmative Insights into the Evolution and ROI of Trade Shows in B2B Marketing

This timely publication delves into the evolving landscape of trade shows and their role in B2B marketing strategies amid the digital transformation era.

Houston, Texas – Blue Atlas Marketing, a leading full-scale digital marketing agency specializing in B2B businesses, today announced the release of its latest in-depth analysis, “Maximizing ROI: Are Trade Shows Still Worth It?”. This timely publication delves into the evolving landscape of trade shows and their role in B2B marketing strategies amid the digital transformation era. The report is now available on the Blue Atlas Marketing blog: https://www.blueatlasmarketing.com/resources/are-trade-shows-worth-it/.  

The press release highlights how trade shows, a longstanding pillar in B2B marketing, are adapting to the digital age. Through a detailed exploration of the shift towards hybrid events that blend in-person and virtual experiences, the analysis provides businesses with essential insights into maximizing trade show investments in 2024 and beyond. 

“In the shifting terrain of trade show dynamics, the integration of digital elements into traditionally in-person events reflects a broader trend toward digitalization across industries,” the article notes. This observation underscores the pressing need for businesses to reassess the value and impact of exhibiting at trade shows in a rapidly evolving market landscape. 

The publication is structured to offer a comprehensive understanding of the current trade show environment, detailing the advantages and challenges of participation. It meticulously examines the strategic importance of trade shows in market research, lead generation, brand awareness, and the potential return on investment (ROI) they offer. Furthermore, it provides actionable strategies for businesses aiming to optimize their trade show outcomes, including leveraging hybrid and virtual trade show models for expanded reach and engagement. 

Key findings from the article indicate that while the nature of trade shows is changing, their significance in B2B marketing remains substantial. The advent of virtual and hybrid models has opened new avenues for businesses to connect with a wider audience, offering opportunities for substantial ROI through strategic planning and execution. 

“Trade shows have not lost their luster in B2B marketing; instead, they’ve adapted and evolved,” said Lauren Stockard, Director of Operations at Blue Atlas Marketing. “Whether through the traditional hustle and bustle of in-person gatherings or the digital corridors of virtual events, trade shows remain indispensable for comprehensive market research, generating high-quality leads, enhancing brand visibility, and opening doors to direct sales.” 

The release of this analysis aligns with Blue Atlas Marketing’s commitment to providing businesses with data-driven insights and strategic guidance to navigate the complex digital marketing landscape successfully. It reflects the agency’s dedication to innovation, transparency, and fostering meaningful connections within the B2B sector. 

About Blue Atlas Marketing 

Blue Atlas Marketing is a full-scale digital marketing agency dedicated to driving leads for B2B sales and marketing efforts. Based in Houston, Texas, and supported by a globally dispersed team, Blue Atlas Marketing specializes in digital marketing, web design, website accessibility, and B2B marketing services. Leveraging a blend of strategic expertise, innovative solutions, and a data-driven approach, Blue Atlas Marketing aims to increase incoming leads, convert more existing traffic, and automate much of the sales process to expand the horizons of brand impact and business growth.  

For more information, visit https://www.blueatlasmarketing.com/  

Media Contact
Company Name: Blue Atlas Marketing
Contact Person: Nathaniel Stockard
Email: Send Email
Phone: 713-244-6643
Address:11601 Shadow Creek Parkway Ste 111-372
City: Pearland
State: TX
Country: United States
Website: https://www.blueatlasmarketing.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Blue Atlas Marketing Shares Affirmative Insights into the Evolution and ROI of Trade Shows in B2B Marketing

eFuse Market Size to Grow $674 million by 2029 | Leading key players are Analog Devices, Inc., STMicroelectronics, Monolithic Power Systems, Inc., Microchip Technology

“Browse 209 market data Tables and 66 Figures spread through 222 Pages and in-depth TOC on “eFuse Market””
The eFuse market is projected to reach USD 674 million by 2029 from an estimated USD 557 million in 2024, at a CAGR of 3.9% during the forecast period.

According to a research report eFuse Market Type (Auto Retry, Latched), Package Type (Small Outline No Lead, Dual Flat No Leads, Quad Flat No Leads, Think Shrink Small Outline Package), Application, End User, & Region – Forecast to 2035″ published by MarketsandMarkets, the eFuse market is projected to reach USD 674 million by 2029 from an estimated USD 557 million in 2024, at a CAGR of 3.9% during the forecast period.

The growing requirement for advanced circuit protection in a variety of high-tech industries is driving up demand for eFuses globally. eFuses are being integrated by end users such as servers, hard disc drives (HDD), and solid-state drives (SSD) in order to protect against power anomalies in data centres, automobile electronics, and consumer electronics. System reliability is improved by the availability of eFuses in varieties like auto-retry and latching, which allow customised protection mechanisms. Compact design needs of contemporary electronic devices are met by packaged kinds such as Thin Shrink Small Outline Package (TSSOP), Dual Flat No Leads (DFN), Quad Flat No Leads (QFN), and Small Outline No Lead (SON), which allow for flexible integration into a variety of applications.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157236196

Solid State drives, by application, is expected to be the largest-growing segment during the forecast period.

Based on application, the eFuse market has been split into up to solid state drives, hard disk drives, servers and data centres  equipment, automotive electronics and other application. The solid state drives segment is expected to be the largest growing segment because solid state drives are becoming more and more used in data centres, enterprise storage, and consumer gadgets due to their advantages over traditional hard disc drives in terms of speed, dependability, and energy economy. eFuses prolong the life of solid state drives and improve data integrity by offering crucial protection against overcurrent and short circuits. The need for eFuses in solid state drives rises in tandem with the need for quicker, more dependable storage solutions, particularly in high-performance computing applications.

The latched segment, by type, is expected to be the fastest-growing segment during the forecast period.

This report segments the eFuse market based on the type as, auto retry and latched. The latched segment is expected to be the fastest-growing in the eFuse market due to its ability to provide persistent protection by remaining in an off state after a fault until manually reset. This feature is crucial for applications requiring high safety standards and minimal downtime, such as in automotive electronics, industrial systems, and critical IT infrastructure. The latched mechanism ensures a robust response to overcurrent conditions, significantly enhancing system reliability and safety.

Asia Pacific is expected to be the largest region in the eFuse market.

Asia Pacific is expected to be the largest region for the eFuse market due to several key factors. Firstly, it houses several rapidly developing economies with booming electronics, automotive, and telecommunications sectors, all of which extensively use eFuses for circuit protection. Secondly, the region is a global manufacturing hub for electronic devices and components, leading to a high demand for eFuses in production processes. Additionally, governments in Asia Pacific are heavily investing in digital infrastructure and renewable energy projects, further driving the demand for sophisticated circuit protection solutions. Finally, the growing consumer electronics market in countries like China, India, and South Korea contributes significantly to the region’s dominance.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=157236196

The eFuse market is served by a mix of large international players with global operational presence and local players with a strong domestic supply network.  Analog Devices, Inc. (US), STMicroelectronics (Switzerland), Monolithic Power Systems, Inc. (US), Microchip Technology (US) and Qorvo, Inc. (US) are the market leaders in the EFuse market. These companies use strategies such as acquisitions, sales contracts, product launches, partnerships to increase their market share.

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ’GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430 Northbrook,

IL 60062

USA : 1-888-600-6441

newsletter@marketsandmarkets.com

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/efuse-market-157236196.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: eFuse Market Size to Grow $674 million by 2029 | Leading key players are Analog Devices, Inc., STMicroelectronics, Monolithic Power Systems, Inc., Microchip Technology

Digital Evidence Management Market Analysis And Trends By Segmentations, Top Key Players, Geographical Expansion, Future Development & Forecast – 2028

“Panasonic (Japan), Motorola Solutions (US), NICE (Israel), OpenText (Canada), Axon (US), Genetec (Canada), Cellebrite (Israel), Safe Fleet (US), VIDIZMO (US), and IBM (US).”
Digital Evidence Management Market by Component (Software, Hardware, & Services), Software (Evidence Collection, Storage & Sharing, Evidence Analytics & Visualization, Evidence Security), Service, Deployment Mode, End User and Region – Global Forecast to 2028

MarketsandMarkets forecasts the digital evidence management market to grow from an estimated USD 7.7 billion in 2023 to USD 13.6 billion by 2028 at a compound annual growth rate (CAGR) of 12.1%. The rising volume of digital evidence and increasing crime rate drive digital evidence management market growth.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137502457

By component, the software segment is expected to account for the largest share in 2023

The digital evidence management market is segmented, by software, into evidence analytics and visualization; evidence security; and evidence collection, storage, and sharing. Evidence analytics and visualization software enable police forces, private investigators, and government agencies to enhance and digitize their entire evidence process by finding patterns that manage leads and predict criminal activities. Vendors offer a range of digital evidence management software for the imaging, processing, and investigation processes. For instance, the imaging software creates a replica of the data on a drive where investigators perform their investigation process while the original data remains untouched.

By service, the digital investigation and consulting segment is expected to account for the largest market share in 2023

Digital investigation and consulting service vendors provide industry, security, and risk experts who hold expertise in mitigating litigations and solving digital evidence legal issues. With a rapid increase in cases related to money laundering, the internet, and cybercrimes, digital investigation and consulting services assist organizations in tracking issues and reducing losses. Some of the digital investigation and consulting services include data recovery and protection, fraud investigation, and crisis management.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=137502457

Unique Features in the Digital Evidence Management Market

Digital evidence management solutions offer complete administration and analysis capabilities by integrating data from several sources, including body-worn cameras, audio recordings, CCTV footage, and digital documents, into a centralised platform.

Strong chain of custody management capabilities provided by these solutions guarantee the validity and integrity of digital evidence at every stage of its lifetime, including gathering, storing, analysing, and presenting it in court.

Digital assets are indexed and organised using sophisticated metadata tagging and categorization techniques by digital evidence management platforms. This allows for effective search and retrieval of digital evidence by taking into account contextual information like time, location, case ID, and kind of evidence.

In order to preserve compliance with privacy and data protection laws, these systems offer secure access control techniques to limit access to sensitive digital evidence. This guarantees that only authorised workers can view, change, or share evidence files.

To detect and stop tampering or altering digital evidence, digital evidence management systems use cryptographic techniques like digital signatures and hash functions to preserve the integrity of the evidence and ensure its admissibility in court.

Major Highlights of the Digital Evidence Management Market

Technology suppliers are expanding their market reach, improving their digital evidence management offerings, and addressing changing client needs in the context of digital investigations through strategic alliances, joint ventures, and acquisitions.

By providing customisable workflows, collaborative tools, and intuitive interfaces, vendors are aiming to improve the usability and productivity of digital evidence management solutions for investigators and legal professionals.

Cross-platform compatible digital evidence management systems are in high demand because they let businesses store and process digital evidence from a variety of sources, including social media, mobile devices, audio recordings, and CCTV footage.

To improve the capacities of forensic analysts and investigators, digital evidence management platforms are combining with forensic analysis tools and software to enable the smooth transfer of digital evidence for additional analysis and investigation.

Due to privacy laws, data protection rules, and cybersecurity concerns, there is a greater focus on security and compliance in digital evidence management. As a result, solutions that include encryption, access restrictions, and compliance features are being used.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=137502457

Top Companies in the Digital Evidence Management Market 

Panasonic (Japan), Motorola Solutions (US), NICE (Israel), OpenText (Canada), and Axon (US) are among a few leading players operating in the digital evidence management market. Major focus was given to the organic and inorganic strategies to expand the customer base of the company. These players have adopted various growth strategies to strengthen their position in the market. These include product launches, contracts, partnerships, mergers and acquisitions, and new product development activities further to expand their presence in the digital evidence management market.

Panasonic is one of the leading manufacturers of electronics and electrical products. The company primarily operates through four segments, namely consumer electronics, housing, automotive, and Business to Business (B2B). Along with these solutions, the company also offers connected solutions and new security and video surveillance platforms, which support the mission of law enforcement agencies. Panasonic offers digital evidence capture & management solutions are offered by Panasonic. The company offers a wide range of evidence capture and management solutions, which include body-worn cameras, in-car cameras, and video processing units. These products are built on Panasonic’s video surveillance excellence. The organization caters to a large clientele across industry verticals and is in North America, Europe, and Asia Pacific.

Motorola Solutions is a provider of mission-critical communication infrastructure, devices, accessories, software, and services. With its wide range of products and services, it caters to the government, public safety, and commercial industry verticals for enhancing its business operations. Motorola operates through its 2 business segments, namely, products and services. The products segment offers various accessories, infrastructure, devices, municipalities, and software. Its product segment benefits the government, public safety, first-responder agencies, and commercial and industrial customers who operate private communications networks and manage a mobile workforce. Motorola’s CommandCentral Vault is a digital evidence management solution that combines all evidence data and manages organizations’ workflows, offering a single-click solution. CommandCentral Vault is a cloud-based solution that helps to aggregate and intelligently organize digital content. CommandCentral Analytics also offers role-based intelligence to identify crimes, track down leads and seamlessly share insights.

Founded in 1999, NICE is an Israel-based company offering end-to-end digital transformation. NICE helps public safety & justice agencies to revolutionize the way data is managed with the help of its cloud-based evidencentral platform. An ecosystem of integrated technologies is offered with the evidencentral platform. These features help combine data to provide a single platform, improving incident response, accelerating investigations, and streamlining evidence sharing and disclosure. Evidencentral platform includes NICE Inform, NICE Investigate, and NICE Justice. The company focuses heavily on its inorganic strategies by partnering with various police departments. NICE partnered with various departments in the US and UK in the past few years. This platform is used by more than 3,000 public safety & justice customers. The evidencentral platform manages more than 20 million evidence items. Nice caters to all types of public safety and criminal justice agencies, from emergency communications centers and police departments to prosecutors and courts.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/digital-evidence-management-market-137502457.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Digital Evidence Management Market Analysis And Trends By Segmentations, Top Key Players, Geographical Expansion, Future Development & Forecast – 2028

Non-Muscle Invasive Bladder Cancer Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | CG Oncology, Pfizer, UroGen Pharma, Janssen Research

The Non-Muscle Invasive Bladder Cancer Market Forecast report offers an in-depth understanding of the Non-Muscle Invasive Bladder Cancer, historical and forecasted epidemiology as well as the Non-Muscle Invasive Bladder Cancer market trends in the 7MM.

DelveInsight’s “Non-Muscle Invasive Bladder Cancer Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Non-Muscle Invasive Bladder Cancer, historical and forecasted epidemiology as well as the Non-Muscle Invasive Bladder Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Non-Muscle Invasive Bladder Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Non-Muscle Invasive Bladder Cancer Market Forecast

 

Some of the key facts of the Non-Muscle Invasive Bladder Cancer Market Report: 

  • The Non-Muscle Invasive Bladder Cancer market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
  • In December 2023, CG Oncology revealed that the US FDA has awarded both Fast Track Designation (FTD) and Breakthrough Therapy Designation (BTD) for cretostimogene grenadenorepvec in high-risk BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with carcinoma in situ, whether accompanied by Ta or T1 (papillary) tumors or not.
  • In December 2023, Johnson & Johnson declared that the US FDA has awarded Breakthrough Therapy Designation (BTD) to TAR-200 for the possible future therapy of patients with BCG-unresponsive high-risk Non-Muscle Invasive Bladder Cancer (NMIBC), who are not suitable for or have chosen not to undergo radical cystectomy.
  • In the seven major markets (7MM), the United States recorded the highest number of cases in 2023, totaling approximately 600,000 prevalent cases. It is anticipated that these cases will continue to rise throughout the forecast period.
  • As per the projections, in Japan, NMIBC was most commonly found in the age group of 70-89, constituting roughly 60% of the total cases observed in 2023.
  • According to DelveInsight’s projections, approximately 600,000 prevalent cases of NMIBC were reported in the US in 2023.
  • As indicated by the American Urological Association and European Association of Urology, Non-Muscle Invasive Bladder Cancer (NMIBC) constitutes around 75% of all bladder cancer cases.
  • As per Valenza et al. (2022), approximately 20–40% of patients experience disease recurrences or persistence after undergoing BCG treatment, leading to their classification as BCG unresponsive.
  • Key Non-Muscle Invasive Bladder Cancer Companies: CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics, Binhui Biopharmaceutical, SURGE Therapeutics, Pfizer, AstraZeneca, ImmunityBio, Inc., Guarionex J. Decastro, Janssen Research & Development, Tollys, Aura Biosciences, Vaxiion Therapeutics, Incyte Corporation, Janssen Pharmaceuticals, Theralase Technologies, BristolMyers Squibb, Asieris Pharmaceuticals, and others
  • Key Non-Muscle Invasive Bladder Cancer Therapies: CG0070, Sasanlimab (PF-06801591), UGN-102 (mitomycin), TAR-200, TARA-002, OH2 injection, STM-416, Durvalumab, BCG+N-803, Cabazitaxel, Cetrelimab, TL-532, AU-011, VAX 014, Pemigatinib, Erdafitinib, TLD 1433, Nivolumab, APL-1202, and others
  • The Non-Muscle Invasive Bladder Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Non-Muscle Invasive Bladder Cancer pipeline products will significantly revolutionize the Non-Muscle Invasive Bladder Cancer market dynamics.

 

Non-Muscle Invasive Bladder Cancer Overview

Non-muscle invasive bladder cancer (NMIBC) is a type of bladder cancer that starts in the innermost lining of the bladder (urothelium) and has not spread beyond the muscular layer of the bladder wall. It typically involves the superficial layers of the bladder lining and does not invade the deeper muscle layers. NMIBC includes two main types: carcinoma in situ (CIS) and papillary tumors (Ta or T1). 

 

Get a Free sample for the Non-Muscle Invasive Bladder Cancer Market Forecast, Size & Share Analysis Report: 

https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market

 

Non-Muscle Invasive Bladder Cancer Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Non-Muscle Invasive Bladder Cancer Epidemiology Segmentation:

The Non-Muscle Invasive Bladder Cancer market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Non-Muscle Invasive Bladder Cancer
  • Prevalent Cases of Non-Muscle Invasive Bladder Cancer by severity
  • Gender-specific Prevalence of Non-Muscle Invasive Bladder Cancer
  • Diagnosed Cases of Episodic and Chronic Non-Muscle Invasive Bladder Cancer

 

Download the report to understand which factors are driving Non-Muscle Invasive Bladder Cancer epidemiology trends @ Non-Muscle Invasive Bladder Cancer Epidemiology Forecast

 

Non-Muscle Invasive Bladder Cancer Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Non-Muscle Invasive Bladder Cancer market or expected to get launched during the study period. The analysis covers Non-Muscle Invasive Bladder Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Non-Muscle Invasive Bladder Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Non-Muscle Invasive Bladder Cancer Therapies and Key Companies

  • CG0070: CG Oncology
  • Sasanlimab (PF-06801591): Pfizer
  • UGN-102 (mitomycin): UroGen Pharma
  • TAR-200: Janssen Research & Development, LLC
  • TARA-002: Protara Therapeutics
  • OH2 injection: Binhui Biopharmaceutical
  • STM-416: SURGE Therapeutics
  • Durvalumab: AstraZeneca
  • BCG+N-803: ImmunityBio, Inc.
  • Cabazitaxel: Guarionex J. Decastro
  • Cetrelimab: Janssen Research & Development
  • TL-532: Tollys
  • AU-011: Aura Biosciences
  • VAX 014: Vaxiion Therapeutics
  • Pemigatinib: Incyte Corporation
  • Erdafitinib: Janssen Pharmaceuticals
  • TLD 1433: Theralase Technologies
  • Nivolumab: BristolMyers Squibb
  • APL-1202: Asieris Pharmaceuticals

 

Discover more about therapies set to grab major Non-Muscle Invasive Bladder Cancer market share @ Non-Muscle Invasive Bladder Cancer Treatment Landscape 

 

Non-Muscle Invasive Bladder Cancer Market Strengths

  • Potent ICI-based gene therapies can alter the disease trajectory, halting its advancement to advanced stages—an impactful stride in managing NMIBC. Their potential to fulfill approval criteria further underscores their pivotal role in advancing NMIBC treatment.
  • Sasanlimab’s ease of subcutaneous administration and compelling clinical effectiveness position it as a standout candidate in the evolving field of cancer immunotherapy.

 

Non-Muscle Invasive Bladder Cancer Market Opportunities

  • The growing focus on research and development to introduce biomarkers for improved diagnosis and the exploration of combination therapy with BCG presents a promising opportunity in the NMIBC market.
  • The emergence of innovative treatments like CG0070, N-803, non-viral plasmid based therapy, and others signifies a promising advancement in NMIBC treatment. These therapies offer targeted and innovative approaches to address cancer.

 

Scope of the Non-Muscle Invasive Bladder Cancer Market Report

  • Study Period: 2020–2034
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Non-Muscle Invasive Bladder Cancer Companies: CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics, Binhui Biopharmaceutical, SURGE Therapeutics, Pfizer, AstraZeneca, ImmunityBio, Inc., Guarionex J. Decastro, Janssen Research & Development, Tollys, Aura Biosciences, Vaxiion Therapeutics, Incyte Corporation, Janssen Pharmaceuticals, Theralase Technologies, BristolMyers Squibb, Asieris Pharmaceuticals, and others
  • Key Non-Muscle Invasive Bladder Cancer Therapies: CG0070, Sasanlimab (PF-06801591), UGN-102 (mitomycin), TAR-200, TARA-002, OH2 injection, STM-416, Durvalumab, BCG+N-803, Cabazitaxel, Cetrelimab, TL-532, AU-011, VAX 014, Pemigatinib, Erdafitinib, TLD 1433, Nivolumab, APL-1202, and others
  • Non-Muscle Invasive Bladder Cancer Therapeutic Assessment: Non-Muscle Invasive Bladder Cancer current marketed and Non-Muscle Invasive Bladder Cancer emerging therapies
  • Non-Muscle Invasive Bladder Cancer Market Dynamics: Non-Muscle Invasive Bladder Cancer market drivers and Non-Muscle Invasive Bladder Cancer market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Non-Muscle Invasive Bladder Cancer Unmet Needs, KOL’s views, Analyst’s views, Non-Muscle Invasive Bladder Cancer Market Access and Reimbursement 

 

To know more about Non-Muscle Invasive Bladder Cancer companies working in the treatment market, visit @ Non-Muscle Invasive Bladder Cancer Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. Non-Muscle Invasive Bladder Cancer Market Report Introduction

2. Executive Summary for Non-Muscle Invasive Bladder Cancer

3. SWOT analysis of Non-Muscle Invasive Bladder Cancer

4. Non-Muscle Invasive Bladder Cancer Patient Share (%) Overview at a Glance

5. Non-Muscle Invasive Bladder Cancer Market Overview at a Glance

6. Non-Muscle Invasive Bladder Cancer Disease Background and Overview

7. Non-Muscle Invasive Bladder Cancer Epidemiology and Patient Population

8. Country-Specific Patient Population of Non-Muscle Invasive Bladder Cancer 

9. Non-Muscle Invasive Bladder Cancer Current Treatment and Medical Practices

10. Non-Muscle Invasive Bladder Cancer Unmet Needs

11. Non-Muscle Invasive Bladder Cancer Emerging Therapies

12. Non-Muscle Invasive Bladder Cancer Market Outlook

13. Country-Wise Non-Muscle Invasive Bladder Cancer Market Analysis (2020–2034)

14. Non-Muscle Invasive Bladder Cancer Market Access and Reimbursement of Therapies

15. Non-Muscle Invasive Bladder Cancer Market Drivers

16. Non-Muscle Invasive Bladder Cancer Market Barriers

17.  Non-Muscle Invasive Bladder Cancer Appendix

18. Non-Muscle Invasive Bladder Cancer Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Non-Muscle Invasive Bladder Cancer Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | CG Oncology, Pfizer, UroGen Pharma, Janssen Research